JavaScript is disabled. Please enable to continue!

Mobile search icon
Formazione >> Webinar e Formazione Online >> Free Webinar "ISO 10993 evolution: In vitro testing approach for regulatory compliance and future opportunities" (1)

Free Webinar "ISO 10993 evolution: In vitro testing approach for regulatory compliance and future opportunities"

Sidebar Image

FREE ONLINE WEBINAR: To continue supporting our customers' needs this webinar is dedicated to manufacturers only. To allow all interested companies attend, maximum two delegates form the same company will be admitted. Due to the type of event and limited audience capacity, participation of companies not included in this category will not be accepted. Attendance will be confirmed from the event's organizers.

DATE: March 15, 2022 | 3.00 PM - 4.00 PM CET

OFFICIAL LANGUAGE: English

ATTENDEES CAPACITY: 250 delegates

SUBMISSION LINK: Event expired 

The event will be hosted within Go ToWebinar platform. Your registration request for this webinar will be submitted to the organizer for approval. You will receive information via email regarding your registration status.

Webinar overview

ISO 10993-23:2021 Biological evaluation of medical devices - Part 23: Tests for irritation has been published last year. This document specifies the procedure for the assessment of medical devices and their constituent materials with regard to their potential to produce irritation by using an in vitro reconstructed human epidermis (RhE) model.

ISO 10993- 23 introduces the shift from in vivo to in vitro for the assessment of irritation potential of medical devices. The standard officially recognizes in vitro as an approved method for understanding, predicting and classifying skin irritation risk in medical devices.  Its robustness is also what makes the in vitro testing a valuable safeguard. This is leading the path towards the transition to alternative toxicology to assess the biocompatibility of devices.  

in vitro science, is evolving at a fast speed introducing new testing approaches based on human reconstructed tissues. When combined with pyrogenicity and cytotoxicity testing, the skin irritation tests is an effective complement to biocompatibility testing manufacturers might perform in the early stages of development. This means that fabricants need to be receptive and responsive to the new methods.

This event offers a unique opportunity to achieve a better understanding of the evolution of the ISO 10993 standard and the application of  validated in vitro test methods. This webinar will provide sound knowledge on the implementation of an in vitro testing strategy, not only in the scope of the recent ISO 10993-23, but also on how alternative methods can be considered an effective and robust approach to in vivo testing.

Taking into account medical device’s intended purpose, this presentation will present key strategic outcomes of in vitro testing to consider when developing your biocompatibility testing strategy. Thanks to the expertise achieved in developing in vitro testing methods, our Regulatory Senior Consultant and in vitro testing Laboratory Manager  will illustrate through specific examples, the range of success of in vitro testing methods as an alternative to in vivo testing.

Topics
  • In vitro assessment: Regulatory overview
  • ISO 10993-23: in vitro assessment of irritation potential of medical devices
  • Specific considerations and changes on sensitization test procedures
  • Additional methods using different tissues
  • Q&A session
Your experts

Francesco Ranzini – In vitro Laboratory Manager, Eurofins Medical Device Testing Italy

Daniele Lioi - HAS Consultant, Senior Consultant, Eurofins Medical Device Testing Italy